A Campylobacter jejuni gene associated with immune-mediated neuropathy

[1]  A. Moran,et al.  Sialylation of Lipooligosaccharide Cores Affects Immunogenicity and Serum Resistance of Campylobacter jejuni , 2000, Infection and Immunity.

[2]  B. Duim,et al.  Molecular Characterization of Campylobacter jejunifrom Patients with Guillain-Barré and Miller Fisher Syndromes , 2000, Journal of Clinical Microbiology.

[3]  H. Endtz,et al.  Campylobacter jejuni lipopolysaccharides from Guillain–Barré syndrome patients induce IgG anti-GM1 antibodies in rabbits , 2000, Journal of Neuroimmunology.

[4]  J. Brisson,et al.  Biosynthesis of Ganglioside Mimics in Campylobacter jejuni OH4384 , 2000, The Journal of Biological Chemistry.

[5]  P. Thibault,et al.  Sialic acid in the lipopolysaccharide of Haemophilus influenzae: strain distribution, influence on serum resistance and structural characterization , 1999, Molecular microbiology.

[6]  R. Moor,et al.  Mammalian leukocytes contain all the genetic information necessary for the development of a new individual. , 1999, Cloning.

[7]  H. Hartung,et al.  Guillain-Barré syndrome, CIDP and other chronic immune-mediated neuropathies. , 1998, Current opinion in neurology.

[8]  G. Mckhann,et al.  Campylobacter jejuni lipopolysaccharides in Guillain-Barré syndrome , 1998, Neurology.

[9]  I. Nachamkin,et al.  Campylobacter Species and Guillain-Barré Syndrome , 1998, Clinical Microbiology Reviews.

[10]  B. Appelmelk,et al.  Review: Molecular mimicry of host structures by lipopolysaccharides of Campylobacter and Helicobacter spp.: implications in pathogenesis , 1996 .

[11]  黒木 茂一.  Campylobacter jejuni strains from patiensts with Guillain-Barré syndrome belong mostly to Penner serogroup 19 and contain β-N-acetylglucosamine residues , 1994 .

[12]  T. Saida,et al.  Campylobacter jejuni strains from patients with guillain‐barré syndrome belong mostly to penner serogrpup 19 and contain β‐N‐acetylglucosamine residues , 1993 .